By Turna Ray
This story was originally posted Dec. 19.
Agendia has added technology to its Symphony suite of breast cancer assays that will allow the company to accept and analyze paraffin-embedded tissue samples.
"Coming early 2012, Agendia is able to perform the Symphony cancer assays on formalin-fixed, paraffin-embedded tissue from a paraffin block or unstained slides," Agendia states on its website.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Try GenomeWeb Premium now.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
